Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018
Management to host conference call
WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the second quarter of 2018 on Thursday, August 2, 2018. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates.
The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 1686118. A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event for 30 days.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat CNS diseases. Minerva's proprietary compounds include: roluperidone (MIN-101), in Phase 3 clinical development for schizophrenia; seltorexant (MIN-202 or JNJ-42847922) in Phase 2b clinical development for insomnia and major depressive disorder (MDD); MIN-117, in clinical development for MDD; and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV." For more information, please visit www.minervaneurosciences.com.
William B. Boni
VP, Investor Relations/Corp. Communications
Minerva Neurosciences, Inc.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Minerva Neurosciences, Inc. via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Kim Crawford Wines Partners With US Open Tennis Championships25.6.2019 16:00:00 CEST | Pressemelding
No. 1-Selling Sauvignon Blanc in U.S. Becomes the Official Wine of the US Open Tennis Championships in New, Multi-Year Agreement WHITE PLAINS, N.Y. and MARLBOROUGH, New Zealand, June 25, 2019 (GLOBE NEWSWIRE) -- The United States Tennis Association (USTA) and Kim Crawford Wines today announced a new partnership that names Kim Crawford Wines as the official wine of the US Open Tennis Championships. The new, multi-year agreement commences with the 2019 Open. The No. 1-selling Sauvignon Blanci and leading New Zealand wine brandii in the U.S., Kim Crawford Wines will #ServeUpKim to US Open fans with a permanent brand presence on the grounds of the USTA Billie Jean King National Tennis Center. Kim Crawford will further support the partnership at retail locations across the country with impactful displays and an exciting sweepstakes, in which the winner will receive an all-expenses paid VIP experience at the 2020 US Open. The sweepstakes begins July 1 and ends August 31, during which consume
Appian Announces Winners of its Annual Hackathon at Appian World25.6.2019 15:00:00 CEST | Pressemelding
RESTON, Va., June 25, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) congratulates the winners of the Appian World 2019 Hackathon. Participants were tasked with leveraging the Appian platform to showcase the effectiveness and speed of low-code development. Hundreds of registrations were narrowed down to three winners by a seasoned panel of judges including Black Girls Code Founder and CEO, Kimberly Bryant and Neil Ward-Dutton, IDC’s VP of AI and DX European Research Practices and Appian executives. Finalists attended Appian World 2019 in San Diego, CA where they showcased their solutions to the all-star panel of judges. The judges based their decisions on the originality of the idea underlying the application, how well that idea was executed by the developer, and the beneficial impact of the solution. The submissions, covering a variety of industries and use cases, all exemplified the power and simplicity of building enterprise applications on the Appian platform. The 2019 winners are:
Painter 2020 Empowers Digital Artists to Achieve Their Perfect Vision25.6.2019 15:00:00 CEST | Pressemelding
New streamlined workflow, GPU-based brushing, and convenient color selection come together in the fastest Painter yet OTTAWA, June 25, 2019 (GLOBE NEWSWIRE) -- Painter 2020, the latest version of the industry’s most powerful and creative digital painting software, sets the standard for professional digital art on macOS and Windows. Allowing artists to realize their creative vision faster than ever, the new Painter® 2020 dramatically accelerates performance across virtually any system, while delivering a streamlined workflow, all-new brushes, enhanced color selection, and more. “Painter continues to redefine today’s professional digital art workflow,” said Chris Pierce, Senior Product Manager for Digital Arts at Corel. “Whether you’re running the latest hardware or your tried-and-true machine, this new version is an absolute game-changer. From experimenting with color to working with layers, the tools you rely on every day are now more accessible and intuitive.” “By leveraging GPU techn
XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa25.6.2019 14:45:00 CEST | Pressemelding
AUSTIN, Texas, June 25, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announces that Alice Gottlieb M.D., Ph.D., will Chair the Company’s upcoming Phase II study in Hidradenitis Suppurativa (HS). Dr. Gottlieb is Medical Director of dermatology at the Mount Sinai Beth Israel Campus, and Clinical Professor at the Icahn School of Medicine at Mount Sinai. She is one of few doctors in the nation board certified in Dermatology, Rheumatology and Internal Medicine. This will be the second study Chaired by Dr. Gottlieb involving bermekimab in HS and the third study conducted for the drug in HS. Dr. Gottlieb received an M.D.-Ph.D. from The Rockefeller University-Cornell University Medical College. Dr. Gottlieb founded the Tufts Dermatology residency program (which formally was shared with Boston University) and served as Chair of Dermatology and Dermatologist-in-Chief of Tufts Medical Center. She also founded the Dermatology Division at UMDNJ-Robert Wood Johnson Medical School where she serve
Mitsubishi Heavy Industries to Acquire Canadair Regional Jet Program from Bombardier Inc.25.6.2019 14:00:00 CEST | Pressemelding
MHI now positioned to transform and lead the underserved regional jet business , with bolster ed customer support services Key step in MHI’s strategy of expanding its aircraft business globally, with a mid-term focus on North America Completes Bombardier’s aerospace transformation and refocus on business aviation TOKYO and MONTRÉAL, June 25, 2019 (GLOBE NEWSWIRE) -- Mitsubishi Heavy Industries, Ltd (MHI) (TOKYO:7011) and Bombardier Inc (TSX: BBD.B) announced today they have entered into a definitive agreement, whereby MHI will acquire Bombardier’s regional jet program for a cash consideration of $550 million USD, payable to Bombardier upon closing, and the assumption by MHI of liabilities amounting to approximately $200 million USD. Under the agreement, Bombardier’s net beneficial interest in the Regional Aircraft Securitization Program (RASPRO), which is valued at approximately $180 million USD, will be transferred to MHI. Pursuant to the agreement, MHI will acquire the maintenance, s
VSBLTY SELECTED BY ENERGETIKA TECHNOLOGIES TO PROVIDE CROWD ANALYTICS TO ENHANCE SAFETY LIGHTING & SECURITY THROUGHOUT LATIN AMERICA25.6.2019 13:44:00 CEST | Pressemelding
Philadelphia, PA, June 25, 2019 (GLOBE NEWSWIRE) -- VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF), a leading retail software and technology company, is teaming with Energetika, an international provider of “intelligent lighting” solutions, to install safety lighting and integrated security to Mexico City, and other Latin American cities designated as a “Smart City.” Accessibility, habitability, sustainability, air quality, noise levels, energy, health and economic vitality are among the elements necessary to be selected as a “Smart City.” Energetika is a leading provider of smart lighting solutions for economically efficient applications that incorporate security. Energetika chose VSBLTY to provide security technology that includes crowd analytics and facial recognition for residential, commercial and governmental applications. VSBLTY technology provides enhanced customer engagement and audience measurement using machine learning and computer vision. Its in